Elevance Health Inc.

NYSE:ELV

414.01 (USD) • At close November 1, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001
Operating Activities:
Net Income 5,9916,0196,0954,5724,8073,7503,842.82,469.82,5602,566.52,711.52,655.52,646.72,887.14,745.92,490.73,345.43,094.92,463.8960.9774.3549.1342.2
Depreciation & Amortization 1,7451,6751,3021,1541,1331,127890.4911.8907.9851908.8740.7637.2103.1107.1105.4586.2604.9633.8279.1245157120.5
Deferred Income Tax -602-76173-5408191-1,272.1126.9-65.930.759.1127.574.3101.861.3-481.4-105.5273.7-102.6-103.464.463.371.4
Stock Based Compensation 289264255283294226169.6164.6148.2168.9146146.5134.8136153.6156177.1246.900000
Change In Working Capital -5352537845,203-192-1,602367.9-574.9727.2-160.7-766.9-671.262.1-2,244.5653.8-1,513.4494.6-41.7248.863-214155-60.8
Accounts Receivables -1,762-2,510-2,138-256-1,053-707-22.2-1,380.5-42.9-1,899.7-418.3189.90000-247.3-776.9-399.7-91.2-251.1-108.1-44.7
Inventory 1,7622,5102,138256593-1,099-53.1780.3919.11,616.5-549.1-146.20000-683.8-741.175.7190.3000
Accounts Payables 1,6402527191,978-593122921.8116.6-219.3-14.4303.6-406.51.5-58.2952.8-106.3324.5847.2188.9279.7265.1333.4-15.9
Other Working Capital -2,1751653,22586182-478.6-91.370.3136.9-103.1-308.460.6-2,186.3-299-1,407.11,101.2629.1383.9-315.8-228-70.3-0.2
Other Non Cash Items 1,173264-24516-62235186.2106.3-161.4-87.1-6.2-254.4-180.7433.2-2,682.81,778.1-153.2-134.5-518.2103.6273.797.1242.1
Operating Cash Flow 8,0618,3998,36410,6886,0613,8274,184.83,204.54,1163,369.33,052.32,744.63,374.41,416.73,038.92,535.44,344.64,044.23,256.71,303.21,143.4991.1654.6
Investing Activities:
Investments In Property Plant And Equipment -1,296-1,152-1,087-1,021-1,077-1,208-790.2-583.6-602.9-626.6-607.3-544.9-519.5-451.4-378.4-345.6-322-193.9-161.8-136.8-110.7-123.3-70.4
Acquisitions Net -1,552-649-3,476-1,9760-1,760-2,079.60-638.97400-4,597-600-0.34,606-192.7-298.5-25.4-2,589.7-2,239.9-3.5-789.6-4.1
Purchases Of Investments -16,236-24,946-18,669-19,492-22,954-9,671-16,374.7-12,101.6-11,895.7-10,798.5-14,886.1-15,636.7-12,478.3-11,009.5-7,554.7-7,018.7-9,901.2-13,632.5-21,987.6-7,249.3-5,120.7-5,059.8-3,957.3
Sales Maturities Of Investments 13,53622,60814,61316,05921,03511,60013,525.711,952.311,779.810,255.913,662.815,915.612,654.310,769.26,229.17,947.69,739.113,302.64,4807,227.34,1154,546.23,484.6
Other Investing Activites -24-421-1,019-894204-220636.4219206.2-545.7-403.8311.41.5-579.5100.8225.613.791.915,838.924.86.314.649.1
Investing Cash Flow -5,572-4,560-9,638-7,324-2,792-1,259-5,082.4-513.9-1,151.5-974.9-2,234.4-4,551.6-942-1,271.53,002.8616.2-768.9-457.3-4,420.2-2,373.9-1,113.6-1,411.9-498.1
Financing Activities:
Debt Repayment -665-3,574-2,118-850-911-1,295-7,815.1-53.2-1,714.5-379.2-1,993.6-1,497.9-705.1-674.1-1,890.8-38.7-509.7-2,162.1-155.1-798.5-10000
Common Stock Issued 1522035,9961,5771,2831,250225.3119.4186301.3524.7110.82,070.3000784.5559.5430.43895730.92,110.2
Common Stock Repurchased -2,775-2,316-1,900-2,700-1,701-1,685-1,997.7191.8-1,515.8-2,998.8-1,620.1-2,496.8-3,039.8-4,360.3-2,638.4-3,276.2-6,151.4-5,109.7-767.4-82.2-217.2-256.20
Dividends Paid -1,395-1,229-1,104-954-818-776-704.9-684-656.6-480.7-448-367.1-357.80000000000
Other Financing Activities 1565,598-451360-11926510,719.3-306.9703.51,734.91,819.26,339.913.21,865.11,126.4-420.74,947.85,349.56,2555,118.557934.6-2,063.6
Financing Cash Flow -3,349-1,318423-2,567-2,266-2,241426.9-732.9-2,997.4-1,822.5-1,717.82,088.9-2,019.2-3,169.3-3,402.8-3,735.6-3,409.9-3,7252,446.52,063.4-260.2709.346.6
Other Information:
Effect Of Forex Changes On Cash -1-14-1070-24.34.1-5.3-7.12.21.1-0.4-3.2-6.700000000
Net Change In Cash -8612,507-8618041,003325-466.41,961.8-38.2564.8-897.7283412.8-3,027.32,632.2-584165.8-138.11,283992.7-230.4288.5203.1
Cash At End Of Period 6,5267,3874,8805,7414,9373,9343,608.94,075.32,113.52,151.71,586.92,484.62,201.61,788.84,816.12,183.92,767.92,602.12,740.21,457.2464.5694.9406.4